1,352
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system

, , , , , , , , , & show all
Pages 5-11 | Received 25 Aug 2010, Accepted 01 Mar 2011, Published online: 08 Jul 2011

References

  • Eichelberger MC, Hassantoufighi A, Wu M, Li M. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Virol J 2008;5:109.
  • Taylor WR, Burhan E, Wertheim H, Soepandi PZ, Horby P, Fox A, Benamore R, de Simone L, Hien TT, Chappuis F. Avian influenza—A review for doctors in travel medicine. Trav Med Inf Dis 2009;20:1–12.
  • Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006;443:45–49.
  • Schünemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG et al.; WHO Rapid Advice Guideline Panel on Avian Influenza. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007;7:21–31.
  • de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005;353:2667–2672.
  • Earhart KC, Elsayed NM, Saad MD, Gubareva LV, Nayel A, Deyde VM et al. Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt. J Infect Public Health 2009;2:74–80.
  • Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH et al. Avian flu: Isolation of drug-resistant H5N1 virus. Nature 2005;437:1108.
  • Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 2005;68:66–74.
  • Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med 2008;74:847–851.
  • Liu AL, Wang HD, Lee SM, Wang YT, Du GH. Structure activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem 2008;16:7141–7147.
  • Miki K, Nagai T, Suzuki K, Tsujimura R, Koyama K, Kinoshita K et al. Anti-influenza virus activity of biflavonoids. Bioorg Med Chem Lett 2007;17:772–775.
  • Guo CT, Takahashi T, Bukawa W, Takahashi N, Yagi H, Kato K et al. Edible bird’s nest extract inhibits influenza virus infection. Antiviral Res 2006;70:140–146.
  • Ryu YB, Curtis-Long MJ, Kim JH, Jeong SH, Yang MS, Lee KW et al. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition. Bioorg Med Chem Lett 2008;18:6046–6049.
  • Ryu YB, Curtis-Long MJ, Lee JW, Kim JH, Kim JY, Kang KY et al. Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata. Bioorg Med Chem 2009;17:2744–2750.
  • Jeong HJ, Ryu YB, Park SJ, Kim JH, Kwon HJ, Kim JH et al. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 2009;17:6816–6823.
  • Yongkiettrakul S, Boonyapakron K, Jongkaewwattana A, Wanitchang A, Leartsakulpanich U, Chitnumsub P et al. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J Virol Methods 2009;156:44–51.
  • Verma R, Boleti E, George AJT. Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 1998;216:165–181.
  • Cattoli G, Terregino C, Brasola V, Rodriguez JF, Capua I. Development and preliminary validation of an ad hoc N1-N3 discriminatory test for the control of avian influenza in Italy. Avian Dis 2003;47:1060–1062.
  • Cattoli G, Milani A, Bettini F, Serena Beato M, Mancin M, Terregino C et al. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a “DIVA” vaccination strategy for avian influenza infections in poultry. Avian Pathol 2006;35:154–159.
  • Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1. Antiviral Res 2009;82:51–58.
  • Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;56:568.
  • Dixon M. The determination of enzyme inhibitor constants. Biochem J 1953;55:170–171.
  • Dalakouras T, Smith BJ, Platis D, Cox MM, Labrou NE. Development of recombinant protein-based influenza vaccine expression and affinity purification of H1N1 influenza virus neuraminidase. J Chromatogr A 2006;1136:48–56.
  • Tanimoto T, Nishimura Y, Matsuura Y, Fuke I, Ishikawa T, Yamanishi K, Tamura S. Expression of influenza neuraminidase in CHO-K1 cells. International Congress Series 2004;1263:568–572.
  • Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04(H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo J Virol 2007;81:12418–12426.
  • Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Véron M, van der Werf S, Naffakh N. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother 2006;50:3809–3815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.